Rare Primary Diffuse Large B-Cell Lymphoma Confined to Bone Marrow: Features and Prognosis
Oncology Research · 2025
DOI: 10.32604/or.2025.063484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Weiwei Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210000, China. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Antineoplastic Combined Chemotherapy Protocols, Bone Marrow, Bone Marrow Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210000, China.
- Department of Pathology, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210000, China.
- Department of Gastroenterology, First Affiliated Hospital, Anhui University of Science & Technology, Huainan, 235000, China.
Zitieren
APA
Chen, W., Zhou, X., Li, H., Yang, Y., Lu, L., Zhu, C., Fang, R., Chu, X., Zhou, S., & Sun, Q. (2025). Rare Primary Diffuse Large B-Cell Lymphoma Confined to Bone Marrow: Features and Prognosis. Oncology Research. https://doi.org/10.32604/or.2025.063484
Vancouver
Chen W, Zhou X, Li H, Yang Y, Lu L, Zhu C, et al. Rare Primary Diffuse Large B-Cell Lymphoma Confined to Bone Marrow: Features and Prognosis. Oncology Research. 2025. doi:10.32604/or.2025.063484
BibTeX
@article{Chen2025,
author = {Chen, Weiwei and Zhou, Xiaodie and Li, Huiyu and Yang, Yuchen and Lu, Lu and Zhu, Chunyan and Fang, Rong and Chu, Xiaoyuan and Zhou, Shuping and Sun, Qian},
title = {Rare Primary Diffuse Large B-Cell Lymphoma Confined to Bone Marrow: Features and Prognosis},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2025.063484}
}
EUVIMED